SCHEMBL2008290

SCHEMBL2008290

O=S(=O)(Cl)Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9722581 0.82
SCHEMBL9312247 0.72
SCHEMBL9540531 0.72
SCHEMBL415976 0.72
SCHEMBL6681816 0.72
SCHEMBL254 0.72
SCHEMBL27986358 0.72 CA5A (0.33)
Chloromethane SCHEMBL27606445 0.71
SCHEMBL4582115 0.67
Methylene Chloride SCHEMBL27606402 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105565405-B A kind of vertical Quick purifying device and its process for purifying water 徐州工程学院 2018-01-19 CN claimed
CN-105565405-A Vertical type rapid water purifying device and water purifying method thereof XUZHOU INST TECHNOLOGY 2016-05-11 CN claimed
US-12589090-B2 Compounds and methods for the treatment of degenerative disorders AQUILUS PHARMACEUTICALS, INC. (US) 2026-03-31 US disclosed
CN-112996756-B Water treatment agent 栗田工业株式会社 2023-12-08 CN disclosed
US-20220047550-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF DEGENERATIVE DISORDERS AQUILUS PHARMACEUTICALS, INC. 2022-02-17 US disclosed
WO-2020154243-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF DEGENERATIVE DISORDERS AQUILUS PHARMACEUTICALS, INC. (US) 2020-07-30 WO disclosed
CN-108164503-B A kind of heteroaromatic and the disubstituted benzenesulfonamides of alkyl side chain and its preparing the application in anti-influenza A virus medicament 武汉大学 2019-09-17 CN disclosed
CN-108164503-A A kind of heteroaromatic and the disubstituted benzenesulfonamides of alkyl side chain and its application in anti-influenza A virus medicament is prepared 武汉大学 2018-06-15 CN disclosed
EP-2681209-B1 COMPOUNDS AND METHODS FOR THE TREATMENT OF PAIN AND OTHER DISORDERS AQUILUS PHARMACEUTICALS INC (US) 2018-05-09 EP disclosed
CN-105565405-B A kind of vertical Quick purifying device and its process for purifying water 徐州工程学院 2018-01-19 CN disclosed
CN-105431436-B Pyrrolo [2,3-D ] pyrimidine derivatives, processes for their preparation and their use as kinase inhibitors 内尔维阿诺医学科学有限公司 2017-11-28 CN disclosed
US-6583179-B2 For therapy of uterine fibroids, endometriosis, polycystic ovarian disease, dysfunctional uterine bleeding, breast cancer and ovarian cancer; depletion of oocytes; spermatocyte depletion; for female and male contraception ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-06-24 US disclosed
US-20020058654-A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-05-16 US disclosed
EP-1086063-A4 NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES ADVANCED MEDICINE INC (US) 2001-03-28 EP disclosed
EP-1086063-A1 NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES Advanced Medicine, Inc. (US) 2001-03-28 EP disclosed
EP-1045826-A1 PROCESS FOR THE PREPARATION OF ISOPROPYL-METHYL- 2-(3-N-PROPOXYPHENOXY)ETHYL]AMINE AstraZeneca AB (SE) 2000-10-25 EP disclosed
WO-1999064050-A9 NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES ADVANCED MEDICINE INC (US) 2000-04-20 WO disclosed
WO-1999064050-A1 NOVEL POTASSIUM CHANNEL DRUGS AND THEIR USES ADVANCED MEDICINE, INC. (US) 1999-12-16 WO disclosed
WO-1999032430-A1 PROCESS FOR THE PREPARATION OF ISOPROPYL-METHYL-[2-(3-N-PROPOXYPHENOXY)ETHYL]AMINE ASTRAZENECA AB (SE) 1999-07-01 WO disclosed
EP-0328279-A1 Preparation of halogenated organic compounds The British Petroleum Company p.l.c. (GB) 1989-08-16 EP disclosed